KSE 100 2,787.4

114,113.9 (2.5%)

KMI 30 4,178.2

170,565.9 (2.5%)

SEARL

Pharmaceuticals

The Searle Company Limited

Current Price

84.04

Change

+2.07

% Change

+2.53%

Day High

85.48

/

Day Low

83.10

Volume

1.35mn

Standardized
As Reported

Income Statement

In Million

	1Q2024	2Q2024	3Q2024	1Q2025	2Q2025	Trend
Net Sales	10,862.09	9,223.19	8,768.34	7,624.18	7,370.67
Cost of sales	-6,710.54	-5,650.13	-5,572.92	-4,159.78	-3,642.74
Gross profit	4,151.55	3,573.06	3,195.42	3,464.40	3,727.94
Selling & distribution expense	-2,146.09	-2,260.20	-2,184.09	-1,809.68	-2,165.13
Administrative expense	-420.61	-485.45	-583.09	-397.68	-499.88
OPERATING PROFIT	1,584.87	827.43	428.25	1,257.05	1,062.94
Other income	28.65	110.63	67.51	39.82	41.19
Other expenses	-40.00	-3.56	8.29	-38.12	10.01
Share of loss from associates	0.00	0.00	0.00	0.00	0.00
Financial expenses	-1,232.18	-922.55	-995.09	-755.23	-646.89
Profit before taxation	341.35	11.96	-491.03	503.54	467.27
Income tax expense	-203.40	-141.40	-113.55	-75.01	9.91
PROFIT FOR THE YEAR	137.95	-129.44	-604.57	428.53	477.19

Balance Sheet

In Million

	1Q2024	2Q2024	3Q2024	1Q2025	2Q2025	Trend
Share Capital	3,900.65	5,114.94	5,114.94	5,114.94	5,114.94
Shareholder Equity	35,189.02	36,085.71	35,486.34	34,873.53	34,514.35
Non Current Liabilities	6,407.66	5,738.32	5,223.99	3,391.95	3,043.68
Current Liabilities	24,288.84	26,409.33	25,878.35	25,006.99	25,746.23
Total Liabilities	30,696.50	32,147.66	31,102.34	28,398.94	28,789.92
Total Capital and Liabilities	65,885.53	68,233.37	66,588.69	63,272.47	63,304.27
Non Current Assets	35,278.27	36,070.71	35,970.77	23,131.44	23,102.29
Current Assets	30,607.26	32,162.65	30,617.91	40,141.02	40,201.98
Total Assets	65,885.53	68,233.37	66,588.69	63,272.47	63,304.27

Cash Flow

In Million

	1Q2024	2Q2024	3Q2024	1Q2025	2Q2025	Trend
Cash from Operation	4,010.28	5,396.68	7,072.40	-663.61	605.85
Cash from Investing Activities	-5,540.62	-7,702.78	-7,792.58	-91.74	-193.76
Cash from Financing	2,831.73	3,164.14	2,685.24	-524.97	-875.98
Net Change in Cash	1,301.41	858.05	1,965.07	-1,280.31	-463.87
Beginning Cash Balance	-11,424.34	-11,424.34	-11,424.34	-8,915.51	-8,915.51
Ending Cash Balance	-10,122.93	-10,566.29	-9,459.27	-10,195.82	-9,379.38

Income Statement

In Million

	Q1 - 2023	Q2 - 2023	Q3 - 2023	Q4 - 2023	Q1 - 2024	Q2 - 2024	Q3 - 2024	Q4 - 2024	Q1 - 2025	Q2 - 2025	Trend
Net Sales	8,213.14	8,642.76	9,569.23	7,544.35	10,862.09	9,223.19	8,768.34	547.04	7,624.18	7,370.67
Cost of Good Sold	4,907.55	4,847.14	5,824.71	5,161.74	6,710.53	5,650.12	5,572.92	2,239.04	4,159.77	3,642.73
Gross Profit / Loss	3,305.59	3,795.61	3,744.52	2,382.61	4,151.55	3,573.06	3,195.42	2,786.08	3,464.40	3,727.94
Other Operating Expenses	2,085.18	2,310.01	2,449.69	1,726.25	2,606.68	2,749.18	2,758.87	1,194.19	2,245.46	2,654.98
Other Income	48.41	77.33	128.90	25.04	28.65	110.63	67.51	396.85	39.82	41.19
Operating Profit / Loss	1,262.92	1,541.47	1,324.27	656.62	1,584.87	827.43	428.25	1,596.12	1,257.05	1,062.94
Financial Charges	793.47	880.78	1,042.86	1,075.66	1,232.17	922.54	995.08	485.15	755.22	646.88
Profit Before Taxation	475.35	682.15	380.87	-394.27	341.35	11.96	-491.03	1,503.58	503.54	467.27
Taxation	-183.35	-268.02	-145.56	-134.16	-203.40	-141.40	-113.55	76.59	-75.01	9.91
Profit / Loss After Taxation	292.00	414.14	235.32	-528.43	137.95	-129.44	-604.57	1,580.17	428.53	477.19
Basic Earning Per Share	0.85	0.93	0.53	-1.51	0.31	-0.23	-1.34	3.33	0.55	-0.72
Diluted Earning Per Share	0.85	0.93	0.53	-1.51	0.31	-0.23	-1.34	3.33	0.55	-0.72

Balance Sheet

In Million

	Q1 - 2023	Q2 - 2023	Q3 - 2023	Q4 - 2023	Q1 - 2024	Q2 - 2024	Q3 - 2024	Q4 - 2024	Q1 - 2025	Q2 - 2025	Trend
Share Capital	3,120.52	3,900.65	3,900.65	3,900.65	3,900.65	5,114.94	5,114.94	5,114.94	5,114.94	5,114.94
Shareholder Equity	30,977.58	31,402.65	31,576.38	31,676.43	35,189.02	36,085.71	35,486.34	34,444.99	34,873.53	34,514.35
Non Current Liabilities	9,573.48	7,609.83	7,061.46	6,781.43	6,407.66	5,738.32	5,223.99	3,897.79	3,391.95	3,043.68
Current Liabilities	16,613.58	20,471.44	23,747.81	24,037.95	24,288.84	26,409.33	25,878.35	25,217.97	25,006.99	25,746.23
Total Liabilities	26,187.06	28,081.27	30,809.28	30,819.38	30,696.50	32,147.66	31,102.34	29,115.77	28,398.94	28,789.92
Total Capital & Liabilities	57,164.65	59,483.93	62,385.66	62,495.81	65,885.53	68,233.37	66,588.69	63,560.76	63,272.47	63,304.27
Non Current Assets	29,540.86	29,129.61	29,037.39	29,785.82	35,278.27	36,070.71	35,970.77	23,257.90	23,131.44	23,102.29
Current Assets	27,623.78	30,354.31	33,348.26	32,709.98	30,607.26	32,162.65	30,617.91	40,302.86	40,141.02	40,201.98
Total Assets	57,164.65	59,483.93	62,385.66	62,495.81	65,885.53	68,233.37	66,588.69	63,560.76	63,272.47	63,304.27

Cash Flow

In Million

	Q1 - 2023	Q2 - 2023	Q3 - 2023	Q4 - 2023	Q1 - 2024	Q2 - 2024	Q3 - 2024	Q4 - 2024	Q1 - 2025	Q2 - 2025	Trend
Cash Flow From Operating Activities	298.20	-673.14	-436.91	-357.74	4,010.28	5,396.68	7,072.40	4,730.75	-663.61	605.85
Cash Flow From Investing Activities	-168.58	-331.31	19.32	-46.69	-5,540.62	-7,702.78	-7,792.58	-4,338.50	-91.74	-193.76
Cash Flow From Financing Activities	-264.50	-788.58	-904.56	-1,956.77	2,831.73	3,164.14	2,685.24	2,116.56	-524.97	-875.98
Net Increase/(Decrease) in Cash and Cash Equivalents	-134.87	-1,793.02	-1,322.14	-2,361.19	1,301.41	858.05	1,965.07	2,508.83	-1,280.31	-463.87
Cash and Cash Equivalents at the Beginning of the Year	-9,063.16	-9,063.16	-9,063.16	-9,063.16	-11,424.34	-11,424.34	-11,424.34	-11,424.34	-8,915.51	-8,915.51
Cash and Cash Equivalents at the End of the Year	-9,198.02	-10,856.17	-10,385.30	-11,424.34	-10,122.93	-10,566.29	-9,459.27	-8,915.51	-10,195.82	-9,379.38